Ekstedt et al., 1969 - Google Patents
Immunity to staphylococcal infection in mice: effect of living versus killed vaccine, role of circulating antibody, and induction of protection-inducing antigen (s) in vitroEkstedt et al., 1969
View PDF- Document ID
- 5308210302587922751
- Author
- Ekstedt R
- Yoshida K
- Publication year
- Publication venue
- Journal of Bacteriology
External Links
Snippet
Mice immunized by sublethal doses of living Staphylococcus aureus strains other than the Smith diffuse strain were significantly more resistant to challenge with the Smith diffuse strain than animals immunized with heat-killed organisms. The increased resistance …
- 108090001123 antibodies 0 title abstract description 24
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Blanden et al. | The host response to Calmette-Guérin bacillus infection in mice | |
| US4197290A (en) | Vaccine | |
| Humphres et al. | Role of antibody in Coxiella burnetii infection | |
| Kostiala et al. | Tularaemia in the rat. I. The cellular basis on host resistance to infection | |
| Ekstedt et al. | Immunity to staphylococcal infection in mice: effect of living versus killed vaccine, role of circulating antibody, and induction of protection-inducing antigen (s) in vitro | |
| Tewari et al. | Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum | |
| Yoshida et al. | Staphylococcal capsular vaccine for preventing mastitis in two herds in Georgia | |
| McIntyre et al. | Passive serum protection of the infant rabbit against experimental cholera | |
| Buchanan et al. | Protection against infection with Neisseria gonorrhoeae by immunization with outer membrane protein complex and purified pili | |
| Seah et al. | The protection of mice against a virulent strain of Trypanosoma cruzi by previous inoculation with an avirulent strain | |
| Hsu et al. | Interactions between macrophages of guinea pigs and Salmonellae III. Bactericidal action and cytophilic antibodies of macrophages of infected guinea pigs | |
| Yoshida et al. | Mouse Virulent Strain of Staphylococcus epidermidis: Relation of Antiphagocytic Activity to the Protection‐Inducing Antigen | |
| Welshimer | Staphylococcal antibody production in response to injections with Listeria monocytogenes | |
| Ekstedt | Studies on Immunity to Staphylococcal Infection in Mice: IV. The Role of Specific and Nonspecific Immunity [with Discussion] | |
| Neiburger et al. | Inhibition of migration of mouse macrophages by tuberculin-sensitive mouse lymphocytes and by mouse migration inhibitory factor | |
| Sarbbr et al. | Immunization studies with irradiated tuberculosis vaccines | |
| Maiti et al. | Role of antibodies and effect of BCG vaccination in experimental candidiasis in mice | |
| Halliburton et al. | Recall of acquired cellular resistance in mice by antigens from killed Brucella | |
| Smith | Mycoplasma mycoides var. mycoides: immunity and mouse-protective antibody | |
| Ichiman et al. | Cross protection in mice with the Smith diffuse strain of Staphylococcus aureus versus a type I a strain of group B streptococci | |
| Cameron | The significance of the endotoxin and pyogenic factor of Corynebacterium pseudotuberculosis in immunity | |
| Sekiya et al. | Protection against experimental Bordetella bronchiseptica infection in mice by active immunization with killed vaccine | |
| Belyaeva et al. | Development and testing of a vaccine against infectious atrophic rhinitis and pasteurellosis in pigs | |
| Carter | A Serological Classification of Pasteurella Multocida | |
| Crist Jr et al. | Characteristics of Rickettsia mooseri infection of normal and immune mice |